NexgenRx Inc. (TSXV:NXG)
Canada flag Canada · Delayed Price · Currency is CAD
0.3400
-0.0200 (-5.56%)
At close: Mar 20, 2026

NexgenRx Income Statement

Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
17.7116.4813.8512.7811.8411.04
Revenue Growth (YoY)
11.77%18.99%8.33%7.94%7.25%15.74%
Cost of Revenue
3.053.353.032.62.031.38
Gross Profit
14.4113.1210.8210.189.819.67
Selling, General & Admin
11.3210.89.798.626.416.71
Depreciation & Amortization Expenses
1.271.271.311.411.330.94
Total Operating Expenses
12.5912.0611.110.037.757.65
Operating Income
1.821.06-0.280.162.072.02
Interest Expense
0-0.03-0.03-0.02-0.06-0.21
Other Non-Operating Income (Expense)
0.04-----
Total Non-Operating Income (Expense)
0.04-0.03-0.03-0.02-0.06-0.21
Pretax Income
1.861.03-0.310.132.011.81
Provision for Income Taxes
0.360.410.030.16-2.01-0.31
Net Income
1.440.61-0.33-0.024.022.12
Net Income to Common
1.440.61-0.33-0.024.022.12
Net Income Growth
466.93%---89.91%-
Shares Outstanding (Basic)
717171707070
Shares Outstanding (Diluted)
777771707574
Shares Change (YoY)
9.56%8.51%0.28%-6.01%0.88%6.10%
EPS (Basic)
0.020.01-0.01-0.060.03
EPS (Diluted)
0.020.01-0.01-0.050.03
EPS Growth
----86.21%-
Free Cash Flow
2.191.061.20.683.72.53
Free Cash Flow Growth
105.69%-11.31%77.23%-81.69%46.03%154.52%
Free Cash Flow Per Share
0.030.010.020.010.050.03
Dividends Per Share
0.0100.0100.0100.010--
Gross Margin
81.33%79.65%78.14%79.67%82.87%87.54%
Operating Margin
10.26%6.42%-1.99%1.23%17.44%18.28%
Profit Margin
8.42%3.73%-2.40%-0.18%33.93%19.16%
FCF Margin
12.36%6.46%8.67%5.30%31.23%22.93%
EBITDA
3.082.321.031.563.42.96
EBITDA Margin
17.40%14.11%7.45%12.22%28.72%26.77%
EBIT
1.821.06-0.280.162.072.02
EBIT Margin
10.26%6.42%-1.99%1.23%17.44%18.28%
Effective Tax Rate
19.65%40.14%-8.82%116.66%-99.91%-16.89%
Updated Sep 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.